Thiamine is a medicine sold in the U.S. under 2 brand and generic names, for beriberi, pellagra and thiamine deficiency. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
From the FDA label for Thiamine Hydrochloride (application ANDA080556). Other thiamine products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.
Wet” beriberi with myocardial failure must be treated as an emergency cardiac condition, and thiamine must be administered slowly by the IV route in this situation (see WARNINGS ). In the treatment of beriberi, 10 to 20 mg of thiamine hydrochloride are given IM three times daily for as long as two weeks. (See WARNINGS regarding repeated injections of thiamine.) An oral therapeutic multivitamin preparation containing 5 to 10 mg thiamine, administered daily for one month, is recommended to achieve body tissue saturation. Infantile beriberi that is mild may respond to oral therapy, but if collapse occurs, doses of 25 mg may cautiously be given IV. Poor dietary habits should be corrected and an abundant and well-balanced dietary intake should be prescribed. Patients with neuritis of pregnancy in whom vomiting is severe enough to preclude adequate oral therapy should receive 5 to 10 mg of thiamine hydrochloride IM daily. In the treatment of Wernicke-Korsakoff syndrome, thiamine hydrochloride has been administered IV in an initial dose of 100 mg, followed by IM doses of 50 to 100 mg daily until the patient is consuming a regular, balanced diet. (See WARNINGS regarding repeated injections of thiamine.) Patients with marginal thiamine status to whom dextrose is being administered should receive 100 mg thiamine hydrochloride in each of the first few liters of…
To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. An occasional individual may develop a hypersensitivity or life-threatening anaphylactic reaction to thiamine, especially after repeated injections. Collapse and death have been reported. A feeling of warmth, pruritus, urticaria, weakness, sweating, nausea, restlessness, tightness of the throat, angioneurotic edema, cyanosis, pulmonary edema, and hemorrhage into the gastrointestinal tract have also been reported. Some tenderness and induration may follow IM use (see WARNINGS ).
A history of sensitivity to thiamine or to any of the ingredients in this drug is a contraindication. (See WARNINGS for further information.)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
| # | Drug | Rating | Type | Form | Generic? | Typical price | |
|---|---|---|---|---|---|---|---|
| 1 | 62/100 | Prescription | Injectable | Generic | $2 | View → | |
| 2 | Not yet rated | Supplement | — | Generic | $2 |
Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.
| Imprint | Strength | Colour | Shape | Maker |
|---|---|---|---|---|
| ENL | 2.5 mg / 1 mg / 7 mg / 13.6 mg / 6.4 mg / 800 ug / 12 mg / 25 ug / 25 ug / 25 ug / 50 ug / 25 ug / 24 mg / 1 mg / 1 mg / 500 ug / 1.83 mg / 3.67 mg | brown | oval | — |
| T9 | 1 mg / 100 mg / 20 mg / 1.7 mg / 10 mg / 6 ug / 5 mg / 150 ug | red | oval | — |
| PN | 780 ug / 75 mg / 15 ug / 18 mg / 3.5 mg / 21 mg / 21 mg / 400 ug / 600 ug / 160 mg / 20 mg / 13 ug / 330 ug / 150 ug / 25 mg / 15 mg / 1.5 mg | white | oval | — |
A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.
From the FDA Enforcement database. A recall covers specific lots — not the drug as a whole.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
| View → |